Q & T Research   Report issue

For profit Phase 2
Founded: Sherbrooke Canada (1994)

Organization Overview

First Clinical Trial
2007
NCT00419263
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Q & T Research Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

autologous microbiome (1 trial)

peramivir (rapivab) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 2)

Substance Withdrawal Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2